Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00156650 · ClinicalTrials.gov registry record · Phase 1
Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00156650 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 23 participants.
The verdict
NCT00156650, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormone) in the testes of men who are on a male contraceptive regimen.
Interventions
- DRUG Acyline
- DRUG Testosterone Gel
- DRUG Depo-Medroxyprogesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00156650
The ClinicalTrials.gov registry entry for NCT00156650 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acyline is the first listed.
NCT00156650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00156650 about?
NCT00156650 is a clinical study titled "Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone (HOP 5) Testicular Aspiration Addendum". This study is being offered to all participants of the ACY-5 study as an optional addition to the male contraceptive study in which they participated. Participation is voluntary. The purpose of this added procedure (Testicular Aspiration-HOP 3) is to determine the amount of testosterone (male hormo...
What is the current status of trial NCT00156650?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2004-12. Estimated completion is 2005-07.
What interventions are being tested in trial NCT00156650?
The interventions under investigation include: Acyline (DRUG), Testosterone Gel (DRUG), Depo-Medroxyprogesterone (DRUG).
Who is sponsoring clinical trial NCT00156650?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.